Skip to main content
OpenTrials

Clinical trial condition

Leukemia

Explore clinical trials studying Leukemia. Study availability and eligibility vary by location and protocol.

4,417 public trials 1,032 recruiting studies
Refine in advanced search Browse all conditions

Leukemia trial results

Completed

Treatment of Older Adults With Acute Lymphoblastic Leukemia

NCT00973752

Conditions
Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Completed

Multicenter, Randomized, Open-label, Parallel-group Study to Compare mLSG15 + KW-0761 to mLSG15

NCT01173887

Conditions
Adult T-Cell Leukemia-Lymphoma, Hematologic Diseases, Hemic and Lymphatic Diseases, +10 more
Locations
  • Fukuoka University Hospital Fukuoka, Japan
  • Kyushu University Hospital Fukuoka, Japan
  • National Kyushu Cancer Center Fukuoka, Japan
  • Imamura Bun-in Hospital Kagoshima, Japan
View all 19 locations
View Trial Details
Completed

Biological Therapy in Treating Patients With Advanced Myelodysplastic Syndrome, Acute or Chronic Myeloid Leukemia, or Acute Lymphoblastic Leukemia Who Are Undergoing Stem Cell Transplantation

NCT00052520

Conditions
Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), +55 more
Locations
  • Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States
View Trial Details
Completed

EPOCH Chemotherapy and Bortezomib for Associated T-Cell Leukemia Lymphoma

NCT01000285

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • University of Miami Hospital/Sylvester Miami, Florida, United States
  • Johns Hopkins University Baltimore, Maryland, United States
  • Washington University School of Medicine St Louis, Missouri, United States
  • Columbia University, College of Physicians and Surgeons New York, United States
View Trial Details
Completed

Dovitinib for Patients With Tumor Pathway Activations Inhibited by Dovitinib

NCT01831726

Conditions
Adnexal Diseases, Bronchial Neoplasms, Carcinoma, Bronchogenic, +47 more
Locations
  • Alabama Oncology Birmingham, Alabama, United States
  • Highlands Oncology Group SC Fayetteville, Arkansas, United States
  • PCR Oncology Pismo Beach, California, United States
  • Sarcoma Oncology Center Santa Monica, California, United States
View all 49 locations
View Trial Details

Related conditions